Scientists engineered phages to act as scaffolds to carry silver nanoparticles. Together, the two bacteria-killing components ...
As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new ...
I describe the practical and emotional experiences of living with oculogyric crises caused by antipsychotic use for 25 years.
Today, the CAFC issued a precedential ruling reversing the Eastern District of Texas’ denial of JMOL that Seagen’s patent ...
Daiichi Sankyo has emerged victorious in appeals court, flipping a prior multimillion-dollar patent verdict on its head and ...
Sacituzumab tirumotecan demonstrated a 31% objective response rate and 71% disease control rate in advanced urothelial ...
According to DataM Intelligence. The Prescription Drugs Market Size, valued at a substantial US$1240.33 billion in 2024, is projected to ...
Investor's Business Daily on MSN
How stock of the day Genmab is leveraging an $8 billion deal to stoke its next chapter
Genmab stock, Thursday's IBD Stock Of The Day, is just below an early entry in a cup case after announcing an $8 billion deal ...
Citi Annual Global Healthcare Conference 2025 December 3, 2025 9:00 AM ESTCompany ParticipantsDavid Hung - Founder, President, ...
Discusses New Strategy and Business Plan Focused on Commercialization and Liquid Biopsy Innovation November 26, 2025 9:00 ...
Objectives Growing evidence suggests that vaccines targeting respiratory pathogens have non-specific and broader effects. We aimed to investigate the non-specific effects of respiratory vaccines on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback